Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy
Phase 4
- Conditions
- Polypoidal Choroidal Vasculopathy
- Interventions
- Procedure: OCTA plus OCT guided 3+PRN regimenProcedure: OCT guided 3+PRN regimenDrug: Anti-VEGF drug
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- Xiaodong Sun
- Target Recruit Count
- 102
- Registration Number
- NCT04380974
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration
Phase 4
- Conditions
- Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Xiaodong Sun
- Target Recruit Count
- 141
- Registration Number
- NCT02802657
- Locations
- 🇨🇳
Central Theater Command General Hospital, Wuhan, Hubei, China
🇨🇳Eye & Ent Hospital of Fudan University, Shanghai, China
🇨🇳Shanghai First People's Hospital, Shanghai, China
News
No news found